Csenge Advisory Group’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.42M | Sell |
3,717
-49
| -1% | -$18.7K | 0.07% | 208 |
|
|
2025
Q1 | $1.26M | Sell |
3,766
-206
| -5% | -$69K | 0.07% | 216 |
|
|
2024
Q4 | $1.19M | Sell |
3,972
-104
| -3% | -$31.2K | 0.06% | 235 |
|
|
2024
Q3 | $1.61M | Sell |
4,076
-4
| -0.1% | -$1.58K | 0.08% | 186 |
|
|
2024
Q2 | $1.31M | Buy |
4,080
+170
| +4% | +$54.6K | 0.07% | 200 |
|
|
2024
Q1 | $1.3M | Buy |
3,910
+235
| +6% | +$78.4K | 0.07% | 212 |
|
|
2023
Q4 | $995K | Sell |
3,675
-277
| -7% | -$75K | 0.06% | 238 |
|
|
2023
Q3 | $972K | Sell |
3,952
-499
| -11% | -$123K | 0.07% | 217 |
|
|
2023
Q2 | $1.35M | Buy |
4,451
+44
| +1% | +$13.4K | 0.09% | 173 |
|
|
2023
Q1 | $1.16M | Hold |
4,407
| – | – | 0.08% | 183 |
|
|
2022
Q4 | $1.06M | Buy |
4,407
+7
| +0.2% | +$1.68K | 0.08% | 211 |
|
|
2022
Q3 | $809K | Buy |
4,400
+34
| +0.8% | +$6.25K | 0.07% | 235 |
|
|
2022
Q2 | $734K | Sell |
4,366
-669
| -13% | -$112K | 0.06% | 270 |
|
|
2022
Q1 | $1.26M | Buy |
5,035
+1,364
| +37% | +$342K | 0.1% | 179 |
|
|
2021
Q4 | $778K | Sell |
3,671
-667
| -15% | -$141K | 0.07% | 249 |
|
|
2021
Q3 | $1.08M | Buy |
4,338
+667
| +18% | +$165K | 0.09% | 206 |
|
|
2021
Q2 | $778K | Buy |
3,671
+2,549
| +227% | +$540K | 0.07% | 250 |
|
|
2021
Q1 | $214K | Buy |
+1,122
| New | +$214K | 0.02% | 465 |
|
|
2018
Q4 | – | Sell |
-344
| Closed | -$48K | – | 714 |
|
|
2018
Q3 | $48K | Buy |
+344
| New | +$48K | 0.02% | 293 |
|